1. Home
  2. SMMT vs DUOL Comparison

SMMT vs DUOL Comparison

Compare SMMT & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMMT
  • DUOL
  • Stock Information
  • Founded
  • SMMT 2003
  • DUOL 2011
  • Country
  • SMMT United States
  • DUOL United States
  • Employees
  • SMMT N/A
  • DUOL N/A
  • Industry
  • SMMT Biotechnology: Pharmaceutical Preparations
  • DUOL Computer Software: Prepackaged Software
  • Sector
  • SMMT Health Care
  • DUOL Technology
  • Exchange
  • SMMT Nasdaq
  • DUOL Nasdaq
  • Market Cap
  • SMMT 14.5B
  • DUOL 14.2B
  • IPO Year
  • SMMT N/A
  • DUOL 2021
  • Fundamental
  • Price
  • SMMT $18.31
  • DUOL $308.46
  • Analyst Decision
  • SMMT Strong Buy
  • DUOL Buy
  • Analyst Count
  • SMMT 4
  • DUOL 11
  • Target Price
  • SMMT $34.75
  • DUOL $338.38
  • AVG Volume (30 Days)
  • SMMT 2.1M
  • DUOL 559.3K
  • Earning Date
  • SMMT 10-30-2024
  • DUOL 11-06-2024
  • Dividend Yield
  • SMMT N/A
  • DUOL N/A
  • EPS Growth
  • SMMT N/A
  • DUOL N/A
  • EPS
  • SMMT N/A
  • DUOL 1.83
  • Revenue
  • SMMT N/A
  • DUOL $689,459,000.00
  • Revenue This Year
  • SMMT N/A
  • DUOL $42.53
  • Revenue Next Year
  • SMMT N/A
  • DUOL $29.26
  • P/E Ratio
  • SMMT N/A
  • DUOL $167.82
  • Revenue Growth
  • SMMT N/A
  • DUOL 42.47
  • 52 Week Low
  • SMMT $1.88
  • DUOL $145.05
  • 52 Week High
  • SMMT $33.89
  • DUOL $330.61
  • Technical
  • Relative Strength Index (RSI)
  • SMMT 41.16
  • DUOL 58.12
  • Support Level
  • SMMT $19.01
  • DUOL $306.74
  • Resistance Level
  • SMMT $22.53
  • DUOL $329.19
  • Average True Range (ATR)
  • SMMT 1.45
  • DUOL 13.32
  • MACD
  • SMMT -0.21
  • DUOL 0.16
  • Stochastic Oscillator
  • SMMT 4.85
  • DUOL 57.90

About SMMT Summit Therapeutics Inc.

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include The Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has three predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test.

Share on Social Networks: